Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$633,148
+$16,038 QoQ
Shares Held
4,040
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#790
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026S.A. Mason LLC holds $12,379,971 across 9 Drug Manufacturers - General names. NVS ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
12,339 | $3,104,985 | |
| 2 | LLY |
ELI LILLY & Co
|
2,467 | $2,958,994 | |
| 3 | AMGN |
Amgen Inc
|
6,408 | $2,320,464 | |
| 4 | JNJ |
Johnson & Johnson
|
7,845 | $1,992,394 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,968 | $638,388 | |
| 6 | NVS |
Novartis AG
This page
|
4,040 | $633,148 | |
| 7 | NVO |
Novo Nordisk A S
|
6,278 | $300,967 | |
| 8 | PFE |
Pfizer Inc
|
9,104 | $219,224 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $633,148 | 4,040 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $617,110 | 4,040 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $556,994 | 4,040 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $518,089 | 4,040 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $488,880 | 4,040 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $450,379 | 4,040 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $393,132 | 4,040 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $464,680 | 4,040 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $430,098 | 4,040 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $390,789 | 4,040 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $428,112 | 4,240 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $431,886 | 4,240 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $427,858 | 4,240 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $390,080 | 4,240 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $375,217 | 4,136 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $314,377 | 4,136 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $349,616 | 4,136 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $362,934 | 4,136 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $361,775 | 4,136 | Shares | Sole | 2022-01-04 | |
| 2021-09-30 | $338,242 | 4,136 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $336,310 | 3,686 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $315,079 | 3,686 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $348,068 | 3,686 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $320,534 | 3,686 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $322,633 | 3,694 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $304,570 | 3,694 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||